icon
0%

Walgreens Boots Alliance WBA - News Analyzed: 3,881 - Last Week: 100 - Last Month: 499

↘ Walgreens Boots Alliance: Ups and Downs in the Bio-Tech Market

Walgreens Boots Alliance: Ups and Downs in the Bio-Tech Market
Shell Asset Management Co. divested 10,968 shares in Walgreens Boot Alliance. Significant changes are necessary for Walgreens Boots Alliance if the company plans to rebound. The pharmacy retail giant is facing a securities law violation lawsuit with shareholders urged to contact the Gross Law Firm for information before September 10, 2024. The company released the results for the third quarter (Q3) of the 2024 fiscal year. Amidst legal implications, the share price increased by 1.4%. EP Wealth Advisors LLC utilized this opportunity and divested shares in Walgreens. The company was awarded the BARDA Project NextGen to lead a novel COVID-19 study. However, amidst these notable happenings, Barclays analysts decreased the price target for Walgreens shares to $7.00. Amid allegations of securities fraud, the company seeks a £7 billion sale and reports a 0.69% stock movement. Q3 earnings missed estimates which resulted in further stock movements and possible investors' waning optimism.

Walgreens Boots Alliance WBA News Analytics from Fri, 22 Dec 2023 08:00:00 GMT to Sun, 28 Jul 2024 16:50:58 GMT - Rating -3 - Innovation -2 - Information 5 - Rumor 4

The email address you have entered is invalid.